Unaltered influenza disease outcomes in swine prophylactically treated with α-galactosylceramide.
Unaltered influenza disease outcomes in swine prophylactically treated with α-galactosylceramide.
复制标题
DOI:
10.1016/j.dci.2020.103843
复制
发表时间:
2021-01
影响因子:
2.9
通讯作者:
Driver JP
中科院分区:
文献类型:
--
作者:
Gu W;Madrid DMD;Yang G;Artiaga BL;Loeb JC;Castleman WL;Richt JA;Lednicky JA;Driver JP
Influenza A viruses (IAV) are a major cause of respiratory diseases in pigs. Invariant natural killer T (iNKT) cells are an innate-like T cell subset that contribute significantly to IAV resistance in mice. In the current work, we explored whether expanding and activating iNKT cells with the iNKT cell superagonists α-galactosylceramide (α-GalCer) would change the course of an IAV infection in pigs. In one study, α-GalCer was administered to pigs intramuscularly (i.m.) 9 days before infection, which systemically expanded iNKT cells. In another study, α-GalCer was administered intranasally (i.n.) 2 days before virus infection to activate mucosal iNKT cells. Despite a synergistic increase in iNKT cells when α-GalCer i.m. treated pigs were infected with IAV, neither approach reduced disease signs, lung pathology, or virus replication. Our results indicate that prophylactic use of iNKT cell agonists to prevent IAV infection is ineffective in pigs. This is significant because this type of approach has been considered for humans whose iNKT cell levels and IAV infections are more similar to those of pigs than mice.
登录
查看更多内容
影响因子:
3.7
作者:
Khiabanian H;Trifonov V;Rabadan R
通讯作者:
Rabadan R
影响因子:
4.8
作者:
Paget, Christophe;Ivanov, Stoyan;Trottein, Francois
通讯作者:
Trottein, Francois
影响因子:
5.5
作者:
Kok, Wai Ling;Denney, Laura;Ho, Ling-Pei
通讯作者:
Ho, Ling-Pei
影响因子:
5.4
作者:
Ho, Ling-Pei;Denney, Laura;McMichael, Andrew J.
通讯作者:
McMichael, Andrew J.
影响因子:
4.4
作者:
Rampuria, Pragya;Lang, Mark L.
通讯作者:
Lang, Mark L.